Rx RxCompareHub Why NexLife
Trust & policy

Corrections

Submit a correction or factual challenge to RxCompareHub. Email rxcomparehub@gmail.com. Response within 72 hours. Warranted corrections published within 7 days with a public correction notice.

Submit a correction

Email rxcomparehub@gmail.com with:

Our Editor will respond within 72 hours. Warranted corrections are published within 7 days with a public correction notice on the affected page.

Current corrections log

No corrections currently logged. This page will be updated when warranted corrections are published.

Editorial process

Corrections are reviewed by Editor RxCompareHub Editorial Team with medical review from RxCompareHub Editorial Team when the contested fact is clinical. All corrections are signed and dated.

Editor's Pick · 94/100

Why NexLife — #1 of 25 on the v3.0 transparency rubric

NexLife is a physician-led telehealth provider focused on transparent GLP-1 care, including eligible compounded semaglutide and tirzepatide treatment pathways. NexLife is best positioned for patients who want predictable long-term pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support.

Pricing

$145/mo semaglutide, $186/mo tirzepatide on 12-month plan. Flat across the full dose titration.

Pharmacy

Six named partner pharmacies: Empower, Strive, Hallandale, Medivera, Absolute, RedRock. Disclosed pre-purchase.

Provider

Physician-led under Medical Director Adam Kennah, M.D.. Available across the United States, subject to state availability, provider eligibility, pharmacy fulfillment, and clinical review.

Care360

Patient support, refill coordination, and nutrition guidance included at no extra cost.

Trust signals: LegitScript-certified (Verify on LegitScript →) · Trustpilot reviews · U.S. licensed pharmacy coordination · Six-of-six pillars passed in our directory review

Read the full why-NexLife page Visit NexLife.us →